News

BioAgilytix announces acquisition of Boston-based clinical research organisation Cambridge Biomedical

Highly complementary transaction strengthens BioAgilytix’s ability to support all phases of biologics development; adds to growing cell and gene therapy expertise; increases laboratory capacity; expands team of seasoned bioanalytical scientists; broadens geographic reach. 4 November 2019 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the…Read more


Validant acquires DataRevive, a regulatory strategy and consulting business focused on novel therapeutics and biologics

1 November 2019 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Validant, regarding the acquisition of DataRevive. Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired DataRevive, a regulatory strategy and consultancy firm that focuses on…Read more


GHO Capital announces the sale of Caprion Biosciences

31 July 2019 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, today announces the sale of Caprion Biosciences (“Caprion”) to Arsenal Capital Partners, a leading specialised private equity firm that invests in middle-market healthcare and specialty industrials companies. Caprion is a specialised laboratory service business serving…Read more


GHO Capital agrees sale of Quotient Sciences to Permira

18 July 2019 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from Quotient Sciences regarding its recapitalisation with global Private Equity Firm Permira: Quotient Sciences and global investment firm Permira today announced that a company backed by the Permira Funds has signed a definitive…Read more


Caprion Biosciences expands its global biomarker and immune monitoring franchise by acquiring Serametrix Corporation

01 May 2019 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Caprion BioSciences, regarding the acquisition of Serametrix Corporation. Caprion Biosciences announced that the company acquired Serametrix Corporation, a specialised provider of immune monitoring services headquartered in Carlsbad, California….Read more


Sterling Pharma Solutions expands its transatlantic presence and development capabilities through acquisition of CiVentiChem in the US

03 April 2019 London, UK – GHO Capital, the European specialist investor in healthcare, acknowledges today’s announcement from its portfolio company, Sterling Pharma Solutions, regarding the acquisition of CiVentiChem in the US. UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina, US….Read more


GHO Capital acquires Sterling Pharma Solutions, a specialist provider of Active Pharmaceutical Ingredient (‘API’) development and manufacturing services to the global biopharmaceutical industry

28 February 2019 London, UK – GHO Capital, the European specialist investor in healthcare, has acquired a majority stake, alongside Management, in Sterling Pharma Solutions (‘Sterling’ or the ‘Company’), a specialist in complex and difficult to manufacture APIs. Headquartered in Newcastle upon Tyne, UK, Sterling is a leading provider of API development and manufacturing, with a…Read more


GHO Capital acquires Validant, a leading quality, compliance and regulatory affairs consulting firm for healthcare companies

20 December 2018 London, UK – GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant, a leading quality, compliance and regulatory affairs consulting firm. Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad…Read more


Caprion Biosciences Expands its Biomarker and Immune Monitoring Franchise by Acquiring US-Based Primity Bio.

21 August 2018 London, UK – GHO Capital, the European specialist investor in healthcare, acknowledges today’s announcement from its portfolio company Caprion Biosciences, Inc. (“Caprion” or “the Company”) regarding the acquisition of US-based Primity Bio. Caprion Biosciences announced today that the company acquired Primity Bio Inc., a specialised provider of biomarker and immune monitoring services…Read more


GHO Capital announces acquisition of Linimed Gruppe GmbH

04 July 2018 London, UK – GHO Capital, the European specialist investor in healthcare, today announces the acquisition of Linimed Gruppe (“Linimed” or “the Company”), a leading provider of outpatient intensive care services across Germany, from Vitruvian Partners and the Linimed founders. Headquartered in Jena, Linimed Gruppe is one of the largest providers of outpatient…Read more